je.st
news
Tag: application
TransCanada delaying application for Energy East Pipeline until 2014
2013-10-04 00:00:27| Oil & Gas - Topix.net
Nearly a year to the day after pop superstar Justin Bieber came to her bedside at the Cross Cancer Institute, social media is abuzz with reports that 19-year-old Crystal Montgomery has died.
Tags: application
east
energy
pipeline
Energy East Pipeline application delayed until 2014: TransCanada
2013-10-03 20:20:51| Energy - Topix.net
TransCanada CEO Russ Girling announces the company is moving forward with the 1.1 million barrel-per-day Energy East Pipeline project at a news conference in Calgary, Aug. 1, 2013.
Tags: application
east
energy
delayed
4 considerations for herbicide application in the fall
2013-10-02 18:53:00| Corn & Soybean Digest
Source: University of Missouri With corn and soybean harvest underway in all major producing states, farmers are thinking about herbicide applications this fall. Aside from weed management, there are other factors to be considered when applying herbicide after harvest including: spring weather uncertainty, impact on soil conditions, pest interactions. read more
Tags: the
application
fall
considerations
Moldtech Inc.'s Custom Application Improves Isolator Protection
2013-10-02 06:00:00| Industrial Newsroom - All News for Today
Lancaster, NY – Moldtech Inc. was asked to manufacture an isolator that would stand up to continual drenching in diesel-fuel-based cutting fluid and would not experience any degradation in isolation performance or fatigue life.<br /> <br /> The traditional isolator manufacturing process bonds natural rubber to metal mounting plates; natural rubber provides optimum isolation ability and excellent fatigue life. The client's isolator had a chemical resistant coating, but constant immersion ...This story is related to the following:Mounting and Attaching ProductsSearch for suppliers of: Isolators |
Tags: application
protection
custom
improves
Vertex Submits Supplemental New Drug Application (sNDA) To U.S. Food And Drug Administration For KALYDECO (ivacaftor) Monotherapy For People With Non-G551D Gating Mutations
2013-10-02 05:50:27| drugdiscoveryonline News Articles
Vertex Pharmaceuticals Incorporated recently announced the submission of a supplemental New Drug Application (sNDA) to the U.S. Food and Drug Administration (FDA) for the approval of KALYDECOTM (ivacaftor) monotherapy for people with cystic fibrosis (CF) ages 6 and older who have at least one non-G551D gating mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) gene
Tags: with
people
food
application
Sites : [342] [343] [344] [345] [346] [347] [348] [349] [350] [351] [352] [353] [354] [355] [356] [357] [358] [359] [360] [361] next »